The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.
 
Nancy Y. Lee
Consulting or Advisory Role - Merck; Merck Serono; pfizer; Sanofi
Research Funding - AstraZeneca; Pfizer (Inst)
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Blueprint Medicines; Cota Healthcare; Eisai; Goldilocks; Lilly; Regeneron; UpToDate
Research Funding - Plexxikon; Regeneron
 
Heiko Schöder
No Relationships to Disclose
 
Sean Matthew McBride
Consulting or Advisory Role - AstraZeneca; Janssen
Research Funding - Genentech
 
Yao Yu
No Relationships to Disclose
 
Jung Kang
No Relationships to Disclose
 
C. Jillian Tsai
No Relationships to Disclose
 
Daphna Y. Gelblum
No Relationships to Disclose
 
Jay Boyle
No Relationships to Disclose
 
Bhuvanesh Singh
No Relationships to Disclose
 
Marc Cohen
No Relationships to Disclose
 
Jennifer R. Cracchiolo
No Relationships to Disclose
 
Ian Ganly
No Relationships to Disclose
 
Lara Dunn
Consulting or Advisory Role - CUE Biopharma; CUE Biopharma; Regeneron
Research Funding - Eisai; Pfizer; Regeneron
 
Anuja Kriplani
No Relationships to Disclose
 
James Vincent Fetten
No Relationships to Disclose
 
Loren S. Michel
Research Funding - Exelixis (Inst)
Travel, Accommodations, Expenses - Immunomedics
 
Richard J. Wong
No Relationships to Disclose
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Incyte
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Nadeem Riaz
Honoraria - PeerView
Consulting or Advisory Role - Mirati Therapeutics; Repare Therapeutics
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Pfizer; Repare Therapeutics
Travel, Accommodations, Expenses - Varian Medical Systems